ReviewACS omega2025
Application of Fe-NPs for Enhancing Methane Production in an Anaerobic Biogas Plant.
Review in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nanoparticle-microbe interactions in biofuel fermentation: current understanding and prospective applications.Nanoscale advances · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Iron nanoparticles (Fe-NPs) have emerged as promising additives for enhancing biogas production through anaerobic digestion (AD). This review comprehensively examines Fe-NP synthesis methods (chemical, physical, and biological), their applications in biogas systems, and their effects on microbial communities. Analysis of recent studies reveals that Fe-NPs can increase methane production by 0.166 to 7 times compared to controls, with optimal concentrations varying from 5.5 to 4330 mg/L depending on nanoparticle type and substrate. Zero-valent iron nanoparticles (nZVI) at 20 mg/L achieved 1.96-fold enhancement, while Fe
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.